Addressing gaps in care of people with conditions affecting sex development and maturation

on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN)

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Differences of sex development are conditions with discrepancies between chromosomal, gonadal and phenotypic sex. In congenital hypogonadotropic hypogonadism, a lack of gonadotropin activity results primarily in the absence of pubertal development with prenatal sex development being (almost) unaffected in most patients. To expedite progress in the care of people affected by differences of sex development and congenital hypogonadotropic hypogonadism, the European Union has funded a number of scientific networks. Two Actions of the Cooperation of Science and Technology (COST) programmes — DSDnet (BM1303) and GnRH Network (BM1105) — provided the framework for ground-breaking research and allowed the development of position papers on diagnostic procedures and special laboratory analyses as well as clinical management. Both Actions developed educational programmes to increase expertise and promote interest in this area of science and medicine. In this Perspective article, we discuss the success of the COST Actions DSDnet and GnRH Network and the European Reference Network for Rare Endocrine Conditions (Endo–ERN), and provide recommendations for future research.

Original languageEnglish
Pages (from-to)615-622
Number of pages8
JournalNature Reviews Endocrinology
Volume15
Issue number10
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Sexual Maturation
Sexual Development
Hypogonadism
Gonadotropin-Releasing Hormone
Technology
European Union
Gonadotropins
Medicine
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN) (2019). Addressing gaps in care of people with conditions affecting sex development and maturation. Nature Reviews Endocrinology, 15(10), 615-622. https://doi.org/10.1038/s41574-019-0238-y

Addressing gaps in care of people with conditions affecting sex development and maturation. / on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN).

In: Nature Reviews Endocrinology, Vol. 15, No. 10, 01.10.2019, p. 615-622.

Research output: Contribution to journalArticle

on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN) 2019, 'Addressing gaps in care of people with conditions affecting sex development and maturation', Nature Reviews Endocrinology, vol. 15, no. 10, pp. 615-622. https://doi.org/10.1038/s41574-019-0238-y
on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN). Addressing gaps in care of people with conditions affecting sex development and maturation. Nature Reviews Endocrinology. 2019 Oct 1;15(10):615-622. https://doi.org/10.1038/s41574-019-0238-y
on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN). / Addressing gaps in care of people with conditions affecting sex development and maturation. In: Nature Reviews Endocrinology. 2019 ; Vol. 15, No. 10. pp. 615-622.
@article{899d61dba9714c1d8e683ede4019d381,
title = "Addressing gaps in care of people with conditions affecting sex development and maturation",
abstract = "Differences of sex development are conditions with discrepancies between chromosomal, gonadal and phenotypic sex. In congenital hypogonadotropic hypogonadism, a lack of gonadotropin activity results primarily in the absence of pubertal development with prenatal sex development being (almost) unaffected in most patients. To expedite progress in the care of people affected by differences of sex development and congenital hypogonadotropic hypogonadism, the European Union has funded a number of scientific networks. Two Actions of the Cooperation of Science and Technology (COST) programmes — DSDnet (BM1303) and GnRH Network (BM1105) — provided the framework for ground-breaking research and allowed the development of position papers on diagnostic procedures and special laboratory analyses as well as clinical management. Both Actions developed educational programmes to increase expertise and promote interest in this area of science and medicine. In this Perspective article, we discuss the success of the COST Actions DSDnet and GnRH Network and the European Reference Network for Rare Endocrine Conditions (Endo–ERN), and provide recommendations for future research.",
author = "{on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN)} and Olaf Hiort and Martine Cools and Alexander Springer and Ken McElreavey and Andy Greenfield and Wudy, {Stefan A.} and Alexandra Kulle and Ahmed, {S. Faisal} and Arianne Dessens and Antonio Balsamo and Mohamad Maghnie and Marco Bonomi and Mehul Dattani and Luca Persani and Laura Audi",
year = "2019",
month = "10",
day = "1",
doi = "10.1038/s41574-019-0238-y",
language = "English",
volume = "15",
pages = "615--622",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Addressing gaps in care of people with conditions affecting sex development and maturation

AU - on behalf of COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN)

AU - Hiort, Olaf

AU - Cools, Martine

AU - Springer, Alexander

AU - McElreavey, Ken

AU - Greenfield, Andy

AU - Wudy, Stefan A.

AU - Kulle, Alexandra

AU - Ahmed, S. Faisal

AU - Dessens, Arianne

AU - Balsamo, Antonio

AU - Maghnie, Mohamad

AU - Bonomi, Marco

AU - Dattani, Mehul

AU - Persani, Luca

AU - Audi, Laura

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Differences of sex development are conditions with discrepancies between chromosomal, gonadal and phenotypic sex. In congenital hypogonadotropic hypogonadism, a lack of gonadotropin activity results primarily in the absence of pubertal development with prenatal sex development being (almost) unaffected in most patients. To expedite progress in the care of people affected by differences of sex development and congenital hypogonadotropic hypogonadism, the European Union has funded a number of scientific networks. Two Actions of the Cooperation of Science and Technology (COST) programmes — DSDnet (BM1303) and GnRH Network (BM1105) — provided the framework for ground-breaking research and allowed the development of position papers on diagnostic procedures and special laboratory analyses as well as clinical management. Both Actions developed educational programmes to increase expertise and promote interest in this area of science and medicine. In this Perspective article, we discuss the success of the COST Actions DSDnet and GnRH Network and the European Reference Network for Rare Endocrine Conditions (Endo–ERN), and provide recommendations for future research.

AB - Differences of sex development are conditions with discrepancies between chromosomal, gonadal and phenotypic sex. In congenital hypogonadotropic hypogonadism, a lack of gonadotropin activity results primarily in the absence of pubertal development with prenatal sex development being (almost) unaffected in most patients. To expedite progress in the care of people affected by differences of sex development and congenital hypogonadotropic hypogonadism, the European Union has funded a number of scientific networks. Two Actions of the Cooperation of Science and Technology (COST) programmes — DSDnet (BM1303) and GnRH Network (BM1105) — provided the framework for ground-breaking research and allowed the development of position papers on diagnostic procedures and special laboratory analyses as well as clinical management. Both Actions developed educational programmes to increase expertise and promote interest in this area of science and medicine. In this Perspective article, we discuss the success of the COST Actions DSDnet and GnRH Network and the European Reference Network for Rare Endocrine Conditions (Endo–ERN), and provide recommendations for future research.

UR - http://www.scopus.com/inward/record.url?scp=85071276722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071276722&partnerID=8YFLogxK

U2 - 10.1038/s41574-019-0238-y

DO - 10.1038/s41574-019-0238-y

M3 - Article

C2 - 31406344

AN - SCOPUS:85071276722

VL - 15

SP - 615

EP - 622

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 10

ER -